News and Stories About targeted therapy
Stage IV Survivor Doing Well Thanks to Clinical Trial
Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today we share the experience of a stage IV pancreatic […]
READ MORE
5 Things to Know About New Pancreatic Cancer Drug Lynparza
The Food and Drug Administration (FDA) recently approved the treatment Lynparza® (olaparib) for use in a group of pancreatic cancer […]
READ MORE
Stage IV Survivor’s Ongoing Clinical Trial Success
Editor’s note: Want to be inspired? Keep reading for a new update on Earl Groce, a stage IV pancreatic cancer […]
READ MORE
Lynparza Approved for Pancreatic Cancer Patients Identified by Testing
Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE
2019 Year in Review: Progress in Research
Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE
Survivor Gains Some Control with Targeted Treatment
Editor’s note: Mary Fox passed away in January 2020. We are grateful she allowed her story to be shared. In […]
READ MORE
Grantee Finds New Pancreatic Cancer Drug Target
The goal of cancer treatment is to identify – and attack – vulnerabilities that make cancer cells different from healthy […]
READ MORE
5 Things to Know about BRCA Mutations and Pancreatic Cancer
Editor’s note: We originally published this blog in 2017. Since then, there have been new developments related to BRCA and […]
READ MORE
34-year-old Survivor Responds Well to Targeted Therapy
When Adam Deal was getting ready for his fraternity brother’s wedding in September 2017, he found himself “practically swimming” in […]
READ MORE
PNET Survivor Receives ‘Gift’ Through Molecular Profiling
The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE
Years Later, Stage IV Survivor Continues Mission to Spread Hope and Create Memories
The name Earl Groce may sound familiar to you. In January 2018, the then two-and-a-half-year survivor lent his voice during […]
READ MORE
Young Mom with Pancreatic Cancer Advocates for Herself
When Allison Perlis of Potomac, Md., first began experiencing symptoms of pancreatic cancer in early 2017, she dismissed them as […]
READ MORE
2018 Year in Review: Top 10 Pancreatic Cancer News Stories
Editor’s note: Today’s edition of the 2018 Year in Review series features the 10 most popular news stories on the […]
READ MORE
2018 Year in Review: Progress in Research, Part 1
Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE
New Cancer Drug Approved Based on Molecular Profiling
The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE
Read How Allison Got on the Right Track
Editor’s note: Allison Lippman got on the Right Track. Learn more. Before Allison Lippman of Dallas met her now-husband, she […]
READ MORE
Meet Our 2018 Research Grantees: Translational Awards
This year, the Pancreatic Cancer Action Network (PanCAN) awarded eight prestigious research grants to scientists and clinicians in the United […]
READ MORE
Survivor Advocates for a Second Opinion
In June 2014, David Wingo went to his doctor about abdominal pain. While investigating the pain, his doctor noticed a […]
READ MORE
Clinical Trial Participant Encourages Patients to Actively Seek Clinical Trials
In September 2015, Earl Groce returned home to North Carolina after driving 5,500 miles cross-country for his first trip to […]
READ MORE
PanCAN’s Precision Medicine Results Featured at Major Meeting
The 2018 Gastrointestinal (GI) Cancers Symposium is taking place in San Francisco, Jan. 18 to 20. The meeting brings together […]
READ MORE
2017 Year in Review: Top 10 News Stories
Editor’s note: This article is another installment in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE
2017 Year in Review: Progress in Research, Part 1
Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE
Discovery of Rare Mutation Gives Survivor Options, Hope
Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE
Forbes Article Discusses Potential of PARP Inhibitors to Treat Certain Pancreatic Cancer Patients
The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE
Studying How a New Immunotherapy Works in Each Patient
Thanks to the generosity of donors, we awarded our largest-ever grant of $2 million in 2016 to accelerate a large-scale […]
READ MORE
Critical Clues Toward Targeting KRAS Mutations
Two new research studies offer encouraging steps toward developing effective therapies to target the notoriously challenging RAS mutations. About 95 […]
READ MORE
